ACTIVITY COUNT
 Related DDCN/DSCN/ISN
Description Where Used Data Elements

Data Elements:
ACTIVITY COUNT (PATIENT LEVEL INFORMATION COSTING)
ACTIVITY COUNT (POINT OF DELIVERY)
ADMITTED PATIENTS IN MONTH TOTAL
ADMITTED PATIENTS RISK ASSESSED FOR VENOUS THROMBOEMBOLISM IN MONTH TOTAL
BENIGN THERAPEUTIC OPERATION NUMBER
COUNT OF DAYS SUSPENDED
DECISION SUPPORT TOOLS FOR NHS CONTINUING HEALTHCARE CARRIED OUT (STANDARD)
DECISION SUPPORT TOOLS FOR NHS CONTINUING HEALTHCARE CARRIED OUT (STANDARD ACUTE HOSPITAL SETTING)
FINAL OUTCOME OF ASSESSMENT CANCER DIAGNOSED TOTAL
FINAL OUTCOME OF ASSESSMENT FAILED TO ATTEND TOTAL
FINAL OUTCOME OF ASSESSMENT NOT KNOWN TOTAL
FINAL OUTCOME OF ASSESSMENT ROUTINE RECALL TOTAL
FINAL OUTCOME OF ASSESSMENT SHORT TERM RECALL TOTAL
HIGH RISK WOMEN INVITED FOR SCREENING IN PERIOD TOTAL
HIGH RISK WOMEN SCREENED TOTAL (TECHNICALLY ADEQUATE)
INVASIVE BREAST CANCER TOTAL
INVASIVE BREAST CANCER TOTAL EXPECTED
INVASIVE BREAST CANCER TOTAL OBSERVED
NHS CONTINUING HEALTHCARE INCOMPLETE LOCAL APPEALS (REPORTING PERIOD END)
NHS CONTINUING HEALTHCARE INCOMPLETE REFERRALS (EXCEEDING 28 DAYS AT REPORTING PERIOD END STANDARD)
NHS CONTINUING HEALTHCARE LOCAL APPEALS COMPLETED
NHS CONTINUING HEALTHCARE LOCAL APPEALS RESULTING IN ELIGIBILITY
NHS CONTINUING HEALTHCARE PREVIOUSLY UNASSESSED PERIODS OF CARE CLAIMS (YEAR TO DATE)
NHS CONTINUING HEALTHCARE REFERRALS
NHS CONTINUING HEALTHCARE REFERRALS (DISCOUNTED BEFORE ASSESSMENT)
NHS CONTINUING HEALTHCARE REFERRALS (EXCEEDING 28 DAYS STANDARD)
NHS CONTINUING HEALTHCARE REFERRALS CONCLUDED
NHS CONTINUING HEALTHCARE REFERRALS CONCLUDED (WITHIN 28 DAYS STANDARD)
NON-INVASIVE OR MICRO-INVASIVE BREAST CANCERS DETECTED (PER 1,000 SCREENED)
OUTCOME OF ASSESSMENT UP TO AND INCLUDING CYTOLOGY AND/OR CORE BIOPSY NOT REFERRED FOR OPEN BIOPSY CANCER TOTAL
OUTCOME OF ASSESSMENT UP TO AND INCLUDING CYTOLOGY AND/OR CORE BIOPSY NOT REFERRED FOR OPEN BIOPSY NO RESULT OR INADEQUATE RESULT TOTAL
OUTCOME OF ASSESSMENT UP TO AND INCLUDING CYTOLOGY AND/OR CORE BIOPSY NOT REFERRED FOR OPEN BIOPSY ROUTINE RECALL TOTAL
OUTCOME OF ASSESSMENT UP TO AND INCLUDING CYTOLOGY AND/OR CORE BIOPSY NOT REFERRED FOR OPEN BIOPSY SHORT TERM RECALL TOTAL
OUTCOME OF ASSESSMENT UP TO AND INCLUDING CYTOLOGY AND/OR CORE BIOPSY REFERRED FOR CYTOLOGY AND/OR CORE BIOPSY TOTAL
OUTCOME OF ASSESSMENT UP TO AND INCLUDING CYTOLOGY AND/OR CORE BIOPSY REFERRED FOR OPEN BIOPSY TOTAL
OUTCOME OF ASSESSMENT UP TO AND INCLUDING OPEN BIOPSY CANCER DIAGNOSED TOTAL
OUTCOME OF ASSESSMENT UP TO AND INCLUDING OPEN BIOPSY NO RESULT OR INADEQUATE RESULT TOTAL
OUTCOME OF ASSESSMENT UP TO AND INCLUDING OPEN BIOPSY RESULT BENIGN OR NORMAL ROUTINE RECALL TOTAL
OUTCOME OF ASSESSMENT UP TO AND INCLUDING OPEN BIOPSY RESULT BENIGN OR NORMAL SHORT TERM RECALL TOTAL
OUTCOME OF ASSESSMENT UP TO AND INCLUDING OPEN BIOPSY TOTAL
OUTCOME OF INITIAL SCREEN NOT KNOWN TOTAL
OUTCOME OF INITIAL SCREEN REFERRED FOR ASSESSMENT TOTAL
OUTCOME OF INITIAL SCREEN ROUTINE RECALL TOTAL
PREGNANCY TOTAL PREVIOUS CAESAREAN SECTIONS
PREGNANCY TOTAL PREVIOUS LIVE BIRTHS
PREGNANCY TOTAL PREVIOUS LOSSES LESS THAN 24 WEEKS
PREGNANCY TOTAL PREVIOUS PREGNANCIES
PREGNANCY TOTAL PREVIOUS STILLBIRTHS
STOP SMOKING LOST TO FOLLOW-UP TOTAL
STOP SMOKING LOST TO FOLLOW-UP TOTAL (PREGNANT WOMEN)
STOP SMOKING NOT QUIT TOTAL
STOP SMOKING NOT QUIT TOTAL (PREGNANT WOMEN)
STOP SMOKING SETTING QUIT DATE TOTAL
STOP SMOKING SETTING QUIT DATE TOTAL (FREE PRESCRIPTION)
STOP SMOKING SUCCESSFULLY QUIT CARBON MONOXIDE VALIDATION TOTAL
STOP SMOKING SUCCESSFULLY QUIT CARBON MONOXIDE VALIDATION TOTAL (PREGNANT WOMEN)
STOP SMOKING SUCCESSFULLY QUIT TOTAL
STOP SMOKING SUCCESSFULLY QUIT TOTAL (FREE PRESCRIPTION)
STOP SMOKING SUCCESSFULLY QUIT TOTAL (PREGNANT WOMEN)
WOMEN ATTENDED FOR ASSESSMENT TOTAL
WOMEN DEFINITELY MICRO-INVASIVE TOTAL
WOMEN INVASIVE STATUS NOT KNOWN TOTAL
WOMEN INVITED FOR SCREENING IN LAST THREE YEARS TOTAL (CALL AND RECALL)
WOMEN INVITED FOR SCREENING IN PERIOD TOTAL
WOMEN INVITED FOR SCREENING IN PERIOD TOTAL (CALL AND RECALL)
WOMEN INVITED TOTAL (OPEN BREAST SCREENING EPISODE)
WOMEN LOST TO FOLLOW-UP TOTAL (AFTER TECHNICALLY INADEQUATE SCREENING MAMMOGRAM)
WOMEN LYMPH NODES PATHOLOGY RESULT NEGATIVE TOTAL
WOMEN LYMPH NODES PATHOLOGY RESULT POSITIVE TOTAL
WOMEN LYMPH NODES PATHOLOGY RESULT UNKNOWN TOTAL
WOMEN NEVER SCREENED TOTAL (NOT SELECTED FOR SCREENING)
WOMEN NEVER SCREENED TOTAL (SELECTED FOR SCREENING)
WOMEN NON-INVASIVE OR POSSIBLY MICRO-INVASIVE TOTAL
WOMEN NOT INVITED TOTAL (OPEN BREAST SCREENING EPISODE)
WOMEN RECALL CEASED TOTAL (UPPER TIER LOCAL AUTHORITY)
WOMEN SCREENED IN LAST THREE YEARS TOTAL
WOMEN SCREENED IN LAST THREE YEARS TOTAL (CALL AND RECALL)
WOMEN SCREENED IN LAST THREE YEARS TOTAL (SELF AND GP REFERRALS)
WOMEN SCREENED IN PERIOD TOTAL
WOMEN SCREENED IN PERIOD TOTAL (CALL AND RECALL)
WOMEN SCREENED IN PERIOD TOTAL (SELF AND GP REFERRALS)
WOMEN SCREENED TOTAL (HIGH RISK EPISODE)
WOMEN SCREENED TOTAL (TECHNICALLY ADEQUATE)
WOMEN TOTAL (HIGH RISK EPISODE)
WOMEN WITH CANCER DIAGNOSED WITHOUT CYTOLOGY OR HISTOLOGY TOTAL
WOMEN WITH CANCER TOTAL
ISO 9001 CERTIFICATION EUROPE